User contributions
Jump to navigation
Jump to search
- 03:21, 22 October 2024 diff hist +7,381 N Development of the PARP chemical talazoparib for the treatment of innovative BRCA1 along with BRCA2 mutated cancer of the breast Created page with "Flow cytometry showed VK-CSNPs steadily retained on the surface of RBC for a long time without affecting the circulation profiles of RBC themselves. The nanoparticles carried..." current